Eli Lilly is on track to become the first trillion-dollar pharma company, fueled by FDA-approved weight loss drugs. With a current valuation of $842 billion, analysts weigh investor risks as competition heats up. read more
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation